Co-Founder & Managing Partner
"At Oak HC/FT, we’re passionate about deploying our collective skills to address important issues in the multi-trillion-dollar Healthcare and FinTech markets. We back innovative companies who are leveraging technology to improve quality, reduce inefficiencies and enhance customer experiences."
Andrew W. Adams (HC) is a Co-Founder and Managing Partner of Oak HC/FT where he focuses on growth equity and early-stage venture opportunities in Healthcare.
Andrew currently serves on the Boards of August Bioservices, Curana Health, DispatchHealth, Eating Recovery Center, Everside Health, Galileo, Infusion for Health, Reveleer, Rialtic, Unified Women's Healthcare, US HealthVest, Veda and WithMe Health. Andrew is also actively involved with Noom and Precision Medicine Group.
Prior investments include Core Informatics (acquired by Thermo Fischer), LDI (acquired by Diplomat Pharmacy), Limeade (ASX: LME), Maestro Health (acquired by AXA Group), One Medical Group (NASDAQ:ONEM) and Therapy Brands (acquired by KKR). Other prior investments include American Esoteric Laboratories (acquired by Sonic Healthcare Limited), Argus Information & Advisory Services (acquired by Verisk Analytics), Benefitfocus (NASDAQ: BNFT), CareMedic Systems (acquired by Ingenix), CLARiENT (acquired by GE Healthcare), Health Dialog (acquired by British United Provident Association), iHealth Technologies (merged with Connolly), Independent Living Systems, NetSpend Corporation (acquired by TSYS), PayFlex Systems (acquired by Aetna), PharMEDium Healthcare (acquired by CD&R) and United BioSource (acquired by Medco Health Solutions).
Andrew has more than 25 years of experience in Healthcare investing. He began his career as an Analyst at Deutsche Banc Alex. Brown.
Andrew received a Bachelor of Arts degree from Princeton University.
Any small, remote beach.
“Here I Go Again” by Whitesnake
“Shoe Dog: A Memoir by the Creator of Nike” by Phil Knight
Alvin, Texas (home of Nolan Ryan)